Delivery Order SPE2DR25D2014-SPE2DR26FA0R9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,105.93 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on October 29, 2025, with completion expected by October 30, 2025. This firm fixed price delivery order represents a pediatric or standard-dose pharmaceutical supply for migraine treatment and falls under a non-competitive, non-set-aside procurement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,320.53 for Imitrex 6 mg/0.5 mL pen injections on December 15, 2025, with completion scheduled for December 16, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $20,289.80 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml pen injectors on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors valued at $2,410.63. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a $4,211.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 1, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency has awarded a $2,288.07 delivery order to AmerisourceBergen Drug Corp for IMITREX 4 mg/0.5 mL pen injectors, with an ultimate completion date of May 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, and the company's corporate office is designated as both the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This firm fixed-price delivery order, valued at $1,071.96, is scheduled for completion by September 9, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0R9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,234.04 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on December 23, 2025, with completion scheduled for December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a purchase of pharmaceutical product under a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and fulfills this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive contract portfolio with DLA demonstrates its established capability to meet federal procurement requirements and serve military healthcare systems, the Defense Health Agency, and other government healthcare entities through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/22/25 |